USAN Watch: April 2013
| USAN | Research Code | InChIKey (Parent) | Drug Class | Therapeutic class | Target |
| aftobetin, aftobetin hydrochloride | ANCA-11, NCE-11 | synthetic small molecule | imaging agent | n/a | |
| anifrolumab | MEDI-546 | n/a | mAb | therapeutic | interferon a/b receptor |
| cobimetinib fumarate | RG-7420, GDC-0973, XL-518 | synthetic small molecule | therapeutic | MEK | |
| doravirine | MK-1439 | synthetic small molecule | therapeutic | HIV-1 RT | |
| lambrolizumab | MK-3475 | n/a | mAb | therapeutic | PDCD-1 |
| pelareorep | Reolysin, PO-BB-0209 | n/a | virus | therapeutic | n/a |
| plazomicin sulfate | ACHN-490 | natural product derived small molecule | therapeutic | 30S ribosome | |
| ralimetinib, ralimetinib mesylate |
LY-2228820
| synthetic small molecule | therapeutic | MAPK14 | |
| ricolinostat |
ACY-1215, ACY-63
| synthetic small molecule | therapeutic | HDAC | |
| ubrogepant | MK-1602 | synthetic small molecule | therapeutic | CGRP | |
| valbenazine |
NBI-98854
| synthetic small molecule | therapeutic | VMAT2 | |
| velcalcetide hydrochloride |
KAI-4169
| n/a | peptide | therapeutic | CaSr |